Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

BACKGROUND: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that has been found to be increased in type 2 diabetic subjects. However, it still remains unclear if these elevated IL-6 levels are co-incidental or if this cytokine is causally related to the development of insulin resistance and type...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Olaf, Oberhauser, Frank, Saech, Jasemine, Rubbert-Roth, Andrea, Hahn, Moritz, Krone, Wilhelm, Laudes, Matthias
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001451/
https://www.ncbi.nlm.nih.gov/pubmed/21179199
http://dx.doi.org/10.1371/journal.pone.0014328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001451/
https://www.ncbi.nlm.nih.gov/pubmed/21179199
http://dx.doi.org/10.1371/journal.pone.0014328

Ejemplares similares